Gabriel H Robert1, Florence Le Jeune2, Clement Lozachmeur2, Sophie Drapier2, Thibaut Dondaine2, Julie Péron2, Jean-Francois Houvenaghel2, David Travers2, Paul Sauleau2, Bruno Millet2, Marc Vérin2, Dominique Drapier2. 1. From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland. gabriel.hadrien.robert@gmail.com. 2. From the Academic Department of Psychiatry (G.H.R., C.L., T.D., B.M., D.D.), Guillaume Régnier Hospital, Rennes; Nuclear Medicine Unit (F.L.J.), Oncology Department, Eugène Marquis Center, Rennes; Movement Disorders Unit, Neurology Department (S.D., J.-F.H., M.V.), Academic Department of Psychiatry (D.T.), and Neurophysiology Unit, Neurology Department (P.S.), Rennes University Hospital, France; and Neuroscience of Emotion and Affective Dynamics Laboratory (J.P.), Swiss Center for Affective Sciences, Geneva, Switzerland.
Abstract
OBJECTIVE: The current literature provides discrepant results regarding preoperative sociodemographic and clinical factors, and no information about preoperative cerebral metabolic patterns associated with apathy after subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. METHODS: To resolve this issue, we set out to identify preoperative metabolic patterns and sociodemographic and clinical factors associated with increased apathy after STN-DBS. Forty-four patients with Parkinson disease were enrolled in this study. They all underwent STN-DBS. Metabolic activity was assessed with F-18 fluorodeoxyglucose PET 3 months before surgery. Apathy was assessed on the Apathy Evaluation Scale 3 months before and after STN-DBS. We controlled for preoperative age, levodopa therapy, and overall cognitive functions. RESULTS: Increased apathy after STN-DBS was significantly associated with reduced preoperative metabolism within the right ventral striatum. None of the sociodemographic and clinical variables tested were associated with apathy after STN-DBS. CONCLUSIONS: Preoperative PET, but not sociodemographic or clinical factors, is associated with apathy after STN-DBS.
OBJECTIVE: The current literature provides discrepant results regarding preoperative sociodemographic and clinical factors, and no information about preoperative cerebral metabolic patterns associated with apathy after subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. METHODS: To resolve this issue, we set out to identify preoperative metabolic patterns and sociodemographic and clinical factors associated with increased apathy after STN-DBS. Forty-four patients with Parkinson disease were enrolled in this study. They all underwent STN-DBS. Metabolic activity was assessed with F-18 fluorodeoxyglucose PET 3 months before surgery. Apathy was assessed on the Apathy Evaluation Scale 3 months before and after STN-DBS. We controlled for preoperative age, levodopa therapy, and overall cognitive functions. RESULTS:Increased apathy after STN-DBS was significantly associated with reduced preoperative metabolism within the right ventral striatum. None of the sociodemographic and clinical variables tested were associated with apathy after STN-DBS. CONCLUSIONS: Preoperative PET, but not sociodemographic or clinical factors, is associated with apathy after STN-DBS.
Authors: Kévin Ahrweiller; J F Houvenaghel; A Riou; S Drapier; P Sauleau; C Haegelen; P Jannin; M Vérin; X Palard; F Le Jeune Journal: J Neurol Date: 2019-07-26 Impact factor: 4.849
Authors: Adam Nassery; Christina A Palmese; Harini Sarva; Mark Groves; Joan Miravite; Brian Harris Kopell Journal: Curr Neurol Neurosci Rep Date: 2016-10 Impact factor: 5.081
Authors: Fernando Caravaggio; Gagan Fervaha; Yusuke Iwata; Eric Plitman; Jun Ku Chung; Shinichiro Nakajima; Wanna Mar; Philip Gerretsen; Julia Kim; M Mallar Chakravarty; Benoit Mulsant; Bruce Pollock; David Mamo; Gary Remington; Ariel Graff-Guerrero Journal: Int J Geriatr Psychiatry Date: 2017-11-07 Impact factor: 3.485
Authors: Jean-Luc Houeto; Robin Magnard; Jeffrey W Dalley; David Belin; Sebastien Carnicella Journal: Front Psychiatry Date: 2016-05-30 Impact factor: 4.157
Authors: Aron Baumann; Carlos G Moreira; Marta M Morawska; Sophie Masneuf; Christian R Baumann; Daniela Noain Journal: Front Hum Neurosci Date: 2016-11-18 Impact factor: 3.169
Authors: Rotem Dan; Filip Růžička; Ondrej Bezdicek; Evžen Růžička; Jan Roth; Josef Vymazal; Gadi Goelman; Robert Jech Journal: Sci Rep Date: 2017-09-22 Impact factor: 4.379